Format

Send to

Choose Destination
Ann Hematol. 2017 Feb;96(2):317-318. doi: 10.1007/s00277-016-2849-x. Epub 2016 Oct 12.

Calreticulin mutations are exceedingly rare in patients with myelodysplastic syndromes with myelofibrosis.

Author information

1
Department of Hematology, University Hospital Vall d´hebron, Paseo Vall d'Hebron 119-129, Barcelona, Spain. mjmontoro@vhebron.net.
2
Unidad de Diagnóstico Molecular y Celular del Cáncer, IBSAL, IBMCC-Centro de Investigación del Cáncer (USAL-CSIC), Salamanca, Spain.
3
Laboratorio de Hematología, Unidad de Biologia Molecular, ICO-Hospital Germans Trials i Pujol, Instituto de Investigación contra la Leucemia Josep Carreras, Badalona, Spain.
4
Department of Hematology, University Hospital Vall d´hebron, Paseo Vall d'Hebron 119-129, Barcelona, Spain.
5
Servicio de Hematología, Hospital Universitario de León, León, Spain.
6
Instituto de Biomedicina (IBIOMED), Universidad de León, León, Spain.
PMID:
27730343
DOI:
10.1007/s00277-016-2849-x
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center